Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Retatrutide is expected to be a once-weekly subcutaneous injection, similar to other GLP-1 medications
In response to the Novo Nordisk ad, a Hims & Hers spokesperson said, "We take safety, quality, and transparency steps for every customer on our platform
TRIUMPH-4 trial design (Eli Lilly 2025)
2 All three doses met the primary endpoint, with participants loosing an average of 29.8 lbs (12.7%) on the 4 mg dose, 45.4 lbs (19.1%) on the 9 mg dose, and 49.6 lbs (20.8%) on the 12 mg dose, compared to 9.3 lbs (4.0%) on placebo
This one is counterintuitive, but hear the logic
How This Pack Solves Problems: GLP-1 therapy can be life-changing, but the side effects shouldnt stand in the way of your success
